Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-019623
Filing Date
2024-05-15
Accepted
2024-05-15 11:41:31
Documents
42
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 433745
2 ex31-1.htm EX-31.1 17731
3 ex31-2.htm EX-31.2 17490
4 ex32-1.htm EX-32.1 8173
5 form10-q_001.jpg GRAPHIC 2913
  Complete submission text file 0001493152-24-019623.txt   2203511

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cqens-20240331.xsd EX-101.SCH 18003
7 XBRL CALCULATION FILE cqens-20240331_cal.xml EX-101.CAL 35383
8 XBRL DEFINITION FILE cqens-20240331_def.xml EX-101.DEF 48349
9 XBRL LABEL FILE cqens-20240331_lab.xml EX-101.LAB 170524
10 XBRL PRESENTATION FILE cqens-20240331_pre.xml EX-101.PRE 125099
46 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 182184
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
CQENS Technologies Inc. (Filer) CIK: 0001479915 (see all company filings)

EIN.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55470 | Film No.: 24948419
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)